论文信息 - Rindopepimut with Bevacizumab for Patients with Relapsed EGFRvIII-Expressing Glioblastoma (ReACT): Results of a Double-Blind Randomized Phase II Trial - 字舞流文

Rindopepimut with Bevacizumab for Patients with Relapsed EGFRvIII-Expressing Glioblastoma (ReACT): Results of a Double-Blind Randomized Phase II Trial

D. Tran | K. Fink | M. Mrugala | D. O’Rourke | D. Reardon | L. Vitale | L. Nabors | A. Desjardins | J. Sampson | T. Keler | T. Davis | J. Vredenburgh | M. Yellin | D. Bota | C. Turner | Gordon Li | R. Lukas | S. Cruickshank | L. Ashby | Jennifer A Green | Yi He | J. Duic | ReACT trial investigators